DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
June 07, 2023 11:17 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, June 07, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, A LEADING NATIONAL FIRM, Encourages Fulcrum Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FULC
June 05, 2023 14:23 ET
|
The Rosen Law Firm PA
NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022...
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.
June 05, 2023 01:45 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trinseo, Edgio, and Fulcrum and Encourages Investors to Contact the Firm
June 04, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 31, 2023 12:45 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 31, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edgio, Fulcrum, and adidas and Encourages Investors to Contact the Firm
May 30, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 25, 2023 11:40 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Trinseo, Edgio, and Fulcrum and Encourages Investors to Contact the Firm
May 24, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FULC
May 23, 2023 11:22 ET
|
The Rosen Law Firm PA
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022...
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.
May 22, 2023 08:15 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...